A metabolite from a drug against diabetes, a possible treatment for neurodegenerative diseases
- Details
- Category: Projects
-
06 Jun 2019

MIN-102, a metabolite from a drug against diabetes, could be useful for treating some neurodegenerative diseases, as scientists think. To confirm this hypothesis, a project has been launched with the involvement of the CSIC’s Instituto de Investigaciones Biomédicas de Barcelona, the Hospital Universitari 'Sant Joan de Déu' and the University of Lleida. The research project is led by the company Mynorix Therapeutics.
Fagomine, effective in long term prevention of type 2 diabetes risk factors
- Details
- Category: Projects
-
08 Oct 2018

Researchers from the Institute of Advanced Chemistry of Catalonia CSIC study the beneficial effects of natural compounds in food. According to the conclusions of a recent study, fagomine, a natural molecule, counteracts the effects of a high-fat diet.
Scientists study the role of a protein in the non-alcoholic fatty liver disease
- Details
- Category: Projects
-
20 Jul 2018

Scientists at the Institut d'Investigacions Biomèdiques (CSIC-IDIBAPS) and at the Institut de Química Avançada de Catalunya, of the CSIC, have been awarded one of the 6 grants of the BBVA Foundation for biomedical research. The scientists will study the implication of a protein in Nonalcoholic fatty liver disease, which is involved in obesity related diseases.
Obtained a synthetic single molecule which inhibits the anticoagulant heparin
- Details
- Category: Projects
-
03 Sep 2018

Scientists at the IQAC-CSIC have obtained a synthetic single molecule which inhibits heparin, the most used anticoagulant drug nowadays. The development has been possible by dynamic combinatorial chemistry. Dynamic chemistry makes possible quickly discovering active molecules and drugs.
Low cost technology for the early diagnosis of cystinuria
- Details
- Category: Projects
-
17 Apr 2018

Scientists at the Instituto de Química Avanzada de Catalunya of the CSIC have developed a technology for the precise and early diagnosis of cystinuria disease, through urine testing. It is based on molecular networks to produce a measurable signal when some substances are linked to a specific molecule.